全文获取类型
收费全文 | 8729篇 |
免费 | 703篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 392篇 |
妇产科学 | 222篇 |
基础医学 | 978篇 |
口腔科学 | 271篇 |
临床医学 | 688篇 |
内科学 | 2225篇 |
皮肤病学 | 274篇 |
神经病学 | 571篇 |
特种医学 | 352篇 |
外科学 | 1510篇 |
综合类 | 53篇 |
一般理论 | 2篇 |
预防医学 | 729篇 |
眼科学 | 200篇 |
药学 | 413篇 |
中国医学 | 35篇 |
肿瘤学 | 372篇 |
出版年
2023年 | 39篇 |
2022年 | 79篇 |
2021年 | 224篇 |
2020年 | 128篇 |
2019年 | 284篇 |
2018年 | 287篇 |
2017年 | 207篇 |
2016年 | 221篇 |
2015年 | 221篇 |
2014年 | 304篇 |
2013年 | 391篇 |
2012年 | 441篇 |
2011年 | 527篇 |
2010年 | 365篇 |
2009年 | 286篇 |
2008年 | 404篇 |
2007年 | 475篇 |
2006年 | 460篇 |
2005年 | 429篇 |
2004年 | 392篇 |
2003年 | 374篇 |
2002年 | 365篇 |
2001年 | 308篇 |
2000年 | 364篇 |
1999年 | 259篇 |
1998年 | 87篇 |
1997年 | 89篇 |
1996年 | 87篇 |
1995年 | 65篇 |
1994年 | 54篇 |
1993年 | 53篇 |
1992年 | 134篇 |
1991年 | 123篇 |
1990年 | 105篇 |
1989年 | 115篇 |
1988年 | 74篇 |
1987年 | 65篇 |
1986年 | 60篇 |
1985年 | 63篇 |
1984年 | 42篇 |
1983年 | 40篇 |
1982年 | 22篇 |
1981年 | 25篇 |
1980年 | 24篇 |
1979年 | 28篇 |
1978年 | 22篇 |
1975年 | 23篇 |
1973年 | 24篇 |
1972年 | 22篇 |
1969年 | 23篇 |
排序方式: 共有9460条查询结果,搜索用时 15 毫秒
101.
Llau Pitarch JV Díaz Alvarez A Polonio Enríquez F Castro Santamaría M Ruiz Moyano J García Enguita MA 《Revista espa?ola de anestesiología y reanimación》2000,47(7):309-316
Aprotinin is a protease inhibitor of interest for its antifibrinolytic effect of reducing perioperative bleeding in certain types of surgery, with wide use in heart surgery, liver transplantation and vascular surgery. The application of aprotinin during orthopedic surgery has recently been suggested. Such use is controversial, as there is lack of consensus as to the type of patient for whom aprotinin administration would be indicated, the surgical procedure during which it would be most effective (hip or knee arthroplasty, spinal arthrodesis, major tumor or septic surgery), the doses to administer, its safety and its real efficacy for conserving homologous blood. That is to say, there is no agreement as to the cost/benefit relation of aprotinin for the various types of orthopedic surgery. This critical review of the literature leads to the conclusion that aprotinin is a promising drug for use in orthopedic surgery, given that published studies have established the benefit in blood product savings and decreased blood loss during surgery. 相似文献
102.
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Pablo García‐Sanz Juan Carlos Triviño Eva Colás Alejandro Rojo‐Sebastián Ángel García Sonia Gatius María Ruiz Jaime Prat Rafael López‐López Miguel Abal Antonio Gil‐Moreno Jaume Reventós Xavier Matias‐Guiu Gema Moreno‐Bueno 《International journal of cancer. Journal international du cancer》2017,140(7):1551-1563
In developed countries, endometrial carcinoma is the most common cancer that affects the female genital tract. Endometrial carcinoma is divided into two main histological types, type I or endometrioid and type II or non‐endometrioid, each of which have characteristic, although not exclusive, molecular alterations and mutational profiles. Nevertheless, information about the implication and relevance of some of these genes in this disease is lacking. We sought here to identify new recurrently mutated genes in endometrioid cancers that play a role in tumourigenesis and that influence the clinical outcome. We focused on low‐grade, non‐ultramutated tumours as these tumours have a worse prognosis than the ultramutated POLE‐positive endometrioid endometrial carcinomas (EECs). We performed exome‐sequencing of 11 EECs with matched normal tissue and subsequently validated 15 candidate genes in 76 samples. For the first time, we show that mutations in chromatin remodelling‐related genes (KMT2D, KMT2C, SETD1B and BCOR) and in DNA‐repair‐related genes (BRCA1, BRCA2, RAD50 and CHD4) are frequent in this subtype of endometrial cancer. The alterations to these genes occurred with frequencies ranging from 35.5% for KMT2D to 10.5% for BRCA1 and BCOR, with some showing a tendency toward co‐occurrence (RAD50‐KMT2D and RAD50‐SETD1B). All these genes harboured specific mutational hotspots. In addition, the mutational status of KMT2C, KMT2D and SETD1B helps to predict the degree of myometrial invasion, a critical prognostic feature. These results highlight the possible implication of these genes in this disease, creating opportunities for new therapeutic approaches. 相似文献
103.
P Bolufer E Ricart A Lluch C Vazquez A Rodriguez A Ruiz F Llopis J Garcia-Conde R Romero 《Journal of clinical oncology》1992,10(3):438-446
PURPOSE: The present report attempts to clarify whether there is a relationship between aromatase activity (ARAC) and estradiol (E2), hormonal receptors, E2 receptor (ER), and epidermal growth factor receptor (EGFR), as well as with tumor stage and histopathology in human breast cancers. MATERIALS AND METHODS: We studied 225 breast carcinomas, 67 of which were premenopausal and 158 postmenopausal. In each sample, ARAC, EGFR, ER, and E2 were quantified. ARAC was quantified by Thompson and Siiterii's method, EGFR was quantified with a two-point assay method using radioactive iodine (125I)-EGF as ligand, and ER was measured by the Scatchard method using 3H-E2. E2 was quantified by radioimmunoassay in the diethylether tumor extract. RESULTS: ARAC was found in 64% of the cancers studied. There is a strong direct association between ARAC and tumor size in postmenopausal patients (P = .001). In the postmenopausal group, the proportion of ARAC-positive (ARAC+) tumors is significantly higher among ER-positive (ER+) than ER-negative (ER-) ones (P less than .001). ER+ tumors also have significantly higher levels of E2 than do ER- ones (P less than .0001); similarly, ARAC+ tumors have significantly higher levels of E2 than do ARAC- ones (P less than .0001). There is a significant multiple linear correlation between the log of the levels of ARAC, ER, and EGFR and the log of tumor E2 (P less than .0001). The correlation coefficients obtained show that ARAC and ER have a positive effect on tumor E2. CONCLUSION: The results obtained suggest the importance of tumor ARAC in the tumoral levels of E2 and reinforce the possible biologic significance of tumor ARAC, especially in postmenopausal breast carcinoma patients. 相似文献
104.
Osorio E Arango GJ Jiménez N Alzate F Ruiz G Gutiérrez D Paco MA Giménez A Robledo S 《Journal of ethnopharmacology》2007,111(3):630-635
Ethnobotanical and chemotaxonomical studies for antiparasitic activity of Colombian Annonaceae were carried out. In vitro antiprotozoal activity of 36 extracts obtained from six different species was determined against promastigotes of three Leishmania species, epimastigotes of Trypanosoma cruzi and both chloroquine sensitive (F32) and resistant (W2) Plasmodium falciparum. Cytotoxic activity was evaluated in U-937 cells. Active extracts were selected according their selectivity index (SI). Extracts from Annona muricata, Rollinia exsucca, Rollinia pittieri and Xylopia aromatica were active against Leishmania spp. and Trypanosoma cruzi showing IC50 values lower than 25 microg/ml. Hexane extract from Rollinia pittieri leaves was the most selective against Trypanosoma cruzi and Leishmania spp. (IS=10 and 16, respectively). The extracts from Desmopsis panamensis, Pseudomalmea boyacana, Rollinia exsucca and Rollinia pittieri showed good antiplasmodial activity (IC50 < 10 microg/ml). No correlation between antiplasmodial activity and inhibition of beta-hematin production was found. The present study gives specific and useful information about antiprotozoal and cytotoxic activities of some Annonaceae extracts. Results presented here also demonstrate which plants and/or plant parts could be useful in the treatment of leishmaniasis, Chagas' disease and malaria. 相似文献
105.
Lucca R. Policastro Isabela Dolci Andre S. Godoy Jos V. J. Silva Júnior Uriel E. A. Ruiz Igor A. Santos Ana C. G. Jardim Kirandeep Samby Jeremy N. Burrows Timothy N. C. Wells Laura H. V. G. Gil Glaucius Oliva Rafaela S. Fernandes 《Viruses》2022,14(7)
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever, a disabling disease that can cause long-term severe arthritis. Since the last large CHIKV outbreak in 2015, the reemergence of the virus represents a serious public health concern. The morbidity associated with viral infection emphasizes the need for the development of specific anti-CHIKV drugs. Herein, we describe the development and characterization of a CHIKV reporter replicon cell line and its use in replicon-based screenings. We tested 960 compounds from MMV/DNDi Open Box libraries and identified four candidates with interesting antiviral activities, which were confirmed in viral infection assays employing CHIKV-nanoluc and BHK-21 cells. The most noteworthy compound identified was itraconazole (ITZ), an orally available, safe, and cheap antifungal, that showed high selectivity indexes of >312 and >294 in both replicon-based and viral infection assays, respectively. The antiviral activity of this molecule has been described against positive-sense single stranded RNA viruses (+ssRNA) and was related to cholesterol metabolism that could affect the formation of the replication organelles. Although its precise mechanism of action against CHIKV still needs to be elucidated, our results demonstrate that ITZ is a potent inhibitor of the viral replication that could be repurposed as a broad-spectrum antiviral. 相似文献
106.
Juan Marco FigueiraGonalves Rafael Golpe Cristbal Esteban Miguel ngel GarcíaBello Nagore BlancoCid Amaia Aramburu Ignacio GarcíaTalavera María Dolores MartínMartínez Adrian BaezaRuiz Andrea ExpsitoMarrero 《The clinical respiratory journal》2022,16(7):504
BackgroundChronic obstructive pulmonary disease (COPD) is a complex and heterogeneous condition, in which taking into consideration clinical phenotypes and multimorbidity is relevant to disease management. Network analysis, a procedure designed to study complex systems, allows to represent connections between the distinct features found in COPD.MethodsNetwork analysis was applied to a cohort of patients with COPD in order to explore the degree of connectivity between different diseases, taking into account the presence of two phenotypic traits commonly used to categorize patients in clinical practice: chronic bronchitis (CB+/CB−) and the history of previous severe exacerbations (Ex+/Ex−). The strength of association between diseases was quantified using the correlation coefficient Phi (ɸ).ResultsA total of 1726 patients were included, and 91 possible links between 14 diseases were established. Although the four phenotypically defined groups presented a similar underlying comorbidity pattern, with special relevance for cardiovascular diseases and/or risk factors, classifying patients according to the presence or absence of CB implied differences between groups in network density (mean ɸ: 0.098 in the CB− group and 0.050 in the CB+ group). In contrast, between‐group differences in network density were small and of questionable significance when classifying patients according to prior exacerbation history (mean ɸ: 0.082 among Ex− subjects and 0.072 in the Ex+ group). The degree of connectivity of any given disease with the rest of the network also varied depending on the selected phenotypic trait. The classification of patients according to the CB−/CB+ groups revealed significant differences between groups in the degree of conectivity between comorbidities. On the other side, grouping the patients according to the Ex−/Ex+ trait did not disclose differences in connectivity between network nodes (diseases).ConclusionsThe multimorbidity network of a patient with COPD differs according to the underlying clinical characteristics, suggesting that the connections linking comorbidities between them vary for different phenotypes and that the clinical heterogeneity of COPD could influence the expression of latent multimorbidity. Network analysis has the potential to delve into the interactions between COPD clinical traits and comorbidities and is a promising tool to investigate possible specific biological pathways that modulate multimorbidity patterns. 相似文献
107.
108.
Ignacio Ruiz del Olmo Izuzquiza Matilde Bustillo Alonso María Luisa Monforte Cirac Pedro Burgués Prades Carmelo Guerrero Laleona 《Anales de pediatría (Barcelona, Spain : 2003)》2017,86(3):115-121
Objective
To study the epidemiology, clinical features, diagnosis, therapeutic management, and outcome of non-tuberculous mycobacterial lymphadenitis in a paediatric population of Aragón (Spain).Material and methods
A retrospective study was conducted on patients under 15 years-old diagnosed with non-tuberculous mycobacterial lymphadenitis between the years 2000 and 2015. Inclusion criteria: patients with lymphadenitis and positive culture. Quantitative values are shown as mean, rank, and standard deviation, and qualitative data as frequencies.Results
Twenty-seven cases were registered, with a mean age of presentation of 39.9 months (range 10 months–8 years). The mean time between the symptoms onset and first consultation was 1.7 ± 1.1 months. The most frequent location was sub-maxilar in 17/27 cases (63%), on the right side in 59.3%, and size 2.96 ± 1.26 cm. Fistulae were observed in 16/27 cases. Tuberculin test was greater than 10 mm in 7/24 (29.1%). Microbiological cultures were positive for Mycobacterium avium in 14/27 (51.9%), Mycobacterium intracellulare 3/27 (11.1%), and Mycobacterium lentiflavum 3/27 (11.1%). Combined treatment of antibiotics and surgery was given in 16/27 cases (59.8%), medical treatment only in7/27 (25.9%), and surgical exeresis alone in 4/27 (14.8%). Two patients required a new surgery, and one showed severe neutropenia secondary to rifabutin. Only one case (3.7%) suffered from temporary facial palsy as sequel.Conclusions
The most frequent treatment was the combination of antibiotics and surgery. Delay in diagnosis seemed to be responsible for the limited number of exeresis as first option, only one for every seven patients. 相似文献109.
110.
Alejandro Isidoro Pérez Cabeza José Luis Górriz Rafael Bravo Marqués Pedro Antonio Chinchurreta Capote Sergio López Tejero José Antonio González Correa Fidel Ernesto Mesa Prado Almudena Valle Alberca Francisco Ruiz Mateas 《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2021,41(2):216-218